127 related articles for article (PubMed ID: 37944913)
1. CRTC1::TRIM11 cutaneous tumor: An update with local recurrence and lung metastasis in a pediatric patient.
Vest BE; Berrebi KG; Stone MS; Sargen MR; Gerami P
J Cutan Pathol; 2024 Mar; 51(3):181-183. PubMed ID: 37944913
[No Abstract] [Full Text] [Related]
2. Cutaneous melanocytic tumour with CRTC1::TRIM11 fusion in a case with recurrent local lymph node and distant pulmonary metastases at early stage: aggressive rather than indolent?
Yang L; Yin Z; Wei J; Chai J; Zhao D; Liu Y; Tang Y; Cheng H; Zhe W; Fan L
Histopathology; 2023 Jan; 82(2):368-371. PubMed ID: 36177516
[No Abstract] [Full Text] [Related]
3. Cutaneous Melanocytoma With CRTC1-TRIM11 Fusion: Report of 5 Cases Resembling Clear Cell Sarcoma.
Cellier L; Perron E; Pissaloux D; Karanian M; Haddad V; Alberti L; de la Fouchardière A
Am J Surg Pathol; 2018 Mar; 42(3):382-391. PubMed ID: 29240581
[TBL] [Abstract][Full Text] [Related]
4. A case report of cutaneous melanocytoma with CRTC1-TRIM11 fusion: Is CMCT distinct from clear cell sarcoma of soft tissue?
Kashima J; Motoi T; Nishimaki M; Hayashi Y; Ogawa M; Kato I; Yamada R; Tonooka A; Horiguchi SI; Funata N; Hishima T; Yoshino K
Pathol Int; 2019 Aug; 69(8):496-501. PubMed ID: 31276279
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion: a case report.
Duan R; He X; Ma X; Huang F; Hu X
Diagn Pathol; 2024 Jan; 19(1):8. PubMed ID: 38184586
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous Melanocytic Tumor With CRTC1::TRIM11 Translocation : An Emerging Entity Analyzed in a Series of 41 Cases.
Hanna J; Ko JS; Billings SD; Boivin F; Beaudoux O; Pissaloux D; Tirode F; Laga A; Fletcher CDM; de la Fouchardiere A
Am J Surg Pathol; 2022 Nov; 46(11):1457-1466. PubMed ID: 35993578
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous melanocytic tumor with CRTC1::TRIM11 fusion and prominent epidermal involvement: A case report.
Vest BE; Harview CL; Liu V; Swick BL; Berrebi KG; Olivares S; Stone MS; Sargen MR; Gerami P
J Cutan Pathol; 2022 Dec; 49(12):1025-1030. PubMed ID: 35751643
[TBL] [Abstract][Full Text] [Related]
8. CRTC1-TRIM11 fusion defined melanocytic tumors: A series of four cases.
Ko JS; Wang L; Billings SD; Pissaloux D; Tirode F; Berry R; De La Fouchardiere A
J Cutan Pathol; 2019 Nov; 46(11):810-818. PubMed ID: 31237704
[TBL] [Abstract][Full Text] [Related]
9. CRTC1-TRIM11 Fusion in a Case of Metastatic Clear Cell Sarcoma: Are CRTC1-TRIM11 Fusion-bearing Tumors Melanocytomas or Clear Cell Sarcomas?
Bontoux C; Baroudjian B; Le Maignan C; Vercellino L; Farges C; Guillemot D; Pierron G; Lebbé C; Battistella M
Am J Surg Pathol; 2019 Jun; 43(6):861-863. PubMed ID: 30676334
[No Abstract] [Full Text] [Related]
10. Dermal melanocytic tumor with CRTC1-TRIM11 fusion: Report of two additional cases with review of the literature of an emerging entity.
Parra O; Bridge JA; Busam KJ; Shalin SC; Linos K
J Cutan Pathol; 2021 Jul; 48(7):915-924. PubMed ID: 33586183
[TBL] [Abstract][Full Text] [Related]
11. TRIM11 overexpression promotes proliferation, migration and invasion of lung cancer cells.
Wang X; Shi W; Shi H; Lu S; Wang K; Sun C; He J; Jin W; Lv X; Zou H; Shu Y
J Exp Clin Cancer Res; 2016 Jun; 35(1):100. PubMed ID: 27329103
[TBL] [Abstract][Full Text] [Related]
12. Emerging mesenchymal tumour types and biases in the era of ubiquitous sequencing.
Towery EA; Papke DJ
J Clin Pathol; 2023 Dec; 76(12):802-812. PubMed ID: 37550012
[TBL] [Abstract][Full Text] [Related]
13. Tripartite motif-containing protein 11 promotes hepatocellular carcinogenesis through ubiquitin-proteasome-mediated degradation of pleckstrin homology domain leucine-rich repeats protein phosphatase 1.
Yang J; Ye J; Ma T; Tang F; Huang L; Liu Z; Tian S; Cheng X; Zhang L; Guo Z; Tu F; He M; Xu X; Lu X; Wu Y; Zeng X; Zou J; Wang X; Peng W; Zhang P
Hepatology; 2022 Sep; 76(3):612-629. PubMed ID: 34767673
[TBL] [Abstract][Full Text] [Related]
14. Tripartite motif protein 11 (TRIM11), an oncogene for human lung cancer via the DUSP6-mediated ERK1/2 signaling pathway.
Wang XL; Lu SC; Sun C; Jin WG; Fan YW; Shu YS; Shi HC; Min LF
Cancer Biol Ther; 2021 Apr; 22(4):324-332. PubMed ID: 33970779
[TBL] [Abstract][Full Text] [Related]
15. SOX13/TRIM11/YAP axis promotes the proliferation, migration and chemoresistance of anaplastic thyroid cancer.
Tang J; Tian Z; Liao X; Wu G
Int J Biol Sci; 2021; 17(2):417-429. PubMed ID: 33613102
[TBL] [Abstract][Full Text] [Related]
16. High expression of TRIM11 correlates with poor prognosis in patients with hepatocellular carcinoma.
Chen Y; Li L; Qian X; Ge Y; Xu G
Clin Res Hepatol Gastroenterol; 2017 Mar; 41(2):190-196. PubMed ID: 28065743
[TBL] [Abstract][Full Text] [Related]
17. Gene fusions in superficial mesenchymal neoplasms: Emerging entities and useful diagnostic adjuncts.
Fischer GM; Papke DJ
Semin Diagn Pathol; 2023 Jul; 40(4):246-257. PubMed ID: 37156707
[TBL] [Abstract][Full Text] [Related]
18. TRIM11 binds to and destabilizes a key component of the activator-mediated cofactor complex (ARC105) through the ubiquitin-proteasome system.
Ishikawa H; Tachikawa H; Miura Y; Takahashi N
FEBS Lett; 2006 Sep; 580(20):4784-92. PubMed ID: 16904669
[TBL] [Abstract][Full Text] [Related]
19. TRIM11 promotes cell proliferation of non-small cell lung cancer through the inhibition of ferroptosis by AMPK.
Liang Z; Li J; Zhang G; Chen M
Clin Respir J; 2023 Oct; 17(10):1006-1016. PubMed ID: 37604203
[TBL] [Abstract][Full Text] [Related]
20. One step at a time: Melanocytic differentiation in fusion-driven cutaneous neoplasms.
Linos K
J Cutan Pathol; 2023 Dec; 50(12):1116-1118. PubMed ID: 37844955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
